Targetting PED/PEA-15 for diabetes treatment

References

• Greig FH, Nixon GF. Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther. 2014;143:265–274.
   PubMed Web of Science ®Google Scholar
• Kitsberg D, Formstecher E, Fauquet M, et al. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci. 1999;19:8244–8251.
   PubMed Web of Science ®Google Scholar
• Renault F, Formstecher E, Callebaut I, et al. The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes. Biochem Pharmacol. 2003;66:1581–1588.
   PubMed Web of Science ®Google Scholar
• Wei Y. On the quest of cellular functions of PEA-15 and the therapeutic opportunities. Pharmaceuticals (Basel). 2015;8:455–473.
   PubMedGoogle Scholar
• Araujo H, Danziger N, Cordier J, et al. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem. 1993;268:5911–5920.
   PubMed Web of Science ®Google Scholar
• Danziger N, Yokoyama M, Jay T, et al. Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem. 1995;64:1016–1025.
   PubMed Web of Science ®Google Scholar
• Estellés A, Yokoyama M, Nothias F, et al. The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem. 1996;271:14800–14806.
   PubMed Web of Science ®Google Scholar
• Kubes M, Cordier J, Glowinski J, et al. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem. 1998;71:1307–1314.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Vigliotta G, Iavarone C, et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. Embo J. 1998;17:3858–3866.
   PubMed Web of Science ®Google Scholar
• Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J. 1995;14:5579–5588.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Vigliotta G, Cafieri A, et al. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene. 1999;18:4409–4415.
   PubMed Web of Science ®Google Scholar
• Koh PO. Ferulic acid prevents the cerebral ischemic injury-induced decreases of astrocytic phosphoprotein PEA-15 and its two phosphorylated forms. Neurosci Lett. 2012;511:101–105.
   PubMed Web of Science ®Google Scholar
• Koh PO. Melatonin attenuates decrease of protein phosphatase 2A subunit B in ischemic brain injury. J Pineal Res. 2012;52:57–61.
   PubMed Web of Science ®Google Scholar
• Koh PO. Nicotinamide attenuates the decrease of astrocytic phosphoprotein PEA-15 in focal cerebral ischemic injury. J Vet Med Sci. 2012;74:377–380.
   PubMed Web of Science ®Google Scholar
• Koh PO. Gingko biloba extract (EGb 761) attenuates ischemic brain injury-induced reduction in Ca (2+) sensor protein hippocalcin. Lab Anim Res. 2012;28:199–204.
   PubMedGoogle Scholar
• Sharif A, Renault F, Beuvon F, et al. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience. 2004;126:263–275.
   PubMed Web of Science ®Google Scholar
• Song JH, Bellail A, Tse MC, et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J Neurosci. 2006;26:3299–3308.
   PubMed Web of Science ®Google Scholar
• Sharif A, Canton B, Junier MP, et al. PEA-15 modulates TNFalpha intracellular signaling in astrocytes. Ann N Y Acad Sci. 2003;1010:43–50.
   PubMed Web of Science ®Google Scholar
• Hao C, Beguinot F, Condorelli G, et al. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res. 2001;61:1162–1170.
   PubMed Web of Science ®Google Scholar
• Bellail AC, Tse MC, Song JH, et al. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med. 2010;14:1303–1317.
   PubMed Web of Science ®Google Scholar
• Eramo A, Pallini R, Lotti F, et al. Inhibition ofDNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. Cancer Res. 2005;65:11469–11477.
   PubMed Web of Science ®Google Scholar
• Estellés A, Charlton CA, Blau HM. The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev Biol. 1999;216:16–28.
   PubMed Web of Science ®Google Scholar
• Trencia A, Perfetti A, Cassese A, et al. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol. 2003;23:4511–4521.
   PubMed Web of Science ®Google Scholar
• Xiao C, Yang BF, Asadi N, et al. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem. 2002;277:25020–25025.
   PubMed Web of Science ®Google Scholar
• Böck BC, Tagscherer KE, Fassl A, et al. The PEA-15 protein regulates autophagy via activation of JNK. J Biol Chem. 2010;285:21644–21654.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Trencia A, Vigliotta G, et al. Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J Biol Chem. 2002;277:11013–11018.
   PubMed Web of Science ®Google Scholar
• Peacock JW, Palmer J, Fink D, et al. PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15. Mol Cell Biol. 2009;29:1222–1234.
   PubMed Web of Science ®Google Scholar
• Srinivasula SM, Gupta S, Datta P, et al. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem. 2003;278:31469–31472.
   PubMed Web of Science ®Google Scholar
• Trencia A, Fiory F, Maitan MA, et al. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem. 2004;279:46566–46572.
   PubMed Web of Science ®Google Scholar
• Twomey EC, Cordasco DF, Wei Y. Profound conformational changes of PED/PEA-15 in ERK2 complex revealed by NMR backbone dynamics. Biochim Biophys Acta. 2012;1824:1382–1393.
   PubMed Web of Science ®Google Scholar
• Mace PD, Wallez Y, Egger MF, et al. Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat Commun. 2013;4:1681.
   PubMed Web of Science ®Google Scholar
• Callaway K, Abramczyk O, Martin L, et al. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site. Biochemistry. 2007;46:9187–9198.
   PubMed Web of Science ®Google Scholar
• Renganathan H, Vaidyanathan H, Knapinska A, et al. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005;390:729–735.
   PubMed Web of Science ®Google Scholar
• Formstecher E, Ramos JW, Fauquet M, et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell. 2001;1:239–250.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan H, Ramos JW. RSK2 activity is regulated by its interaction with PEA-15. J Biol Chem. 2003;278:32367–32372.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan H, Opoku-Ansah J, Pastorino S, et al. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A. 2007;104:19837–19842.
   PubMed Web of Science ®Google Scholar
• Kaneto H, Matsuoka TA, Kimura T, et al. Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: “the earlier, the better”. J Diabetes. 2016;8:183–189.
   PubMed Web of Science ®Google Scholar
• Stančáková A, Laakso M. Genetics of Type 2 Diabetes. Endocr Dev. 2016;31:203–220.
   PubMedGoogle Scholar
• Kwak SH, Park KS. Recent progress in genetic and epigenetic research on type 2 diabetes. Exp Mol Med. 2016;48:e220.
   PubMed Web of Science ®Google Scholar
• Valentino R, Lupoli GA, Raciti GA, et al. The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes. Diabetologia. 2006;49:3058–3066.
   PubMed Web of Science ®Google Scholar
• Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:1714–1721.
   PubMed Web of Science ®Google Scholar
• Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989;321:337–343.
   PubMed Web of Science ®Google Scholar
• Ungaro P, Teperino R, Mirra P, et al. Hepatocyte nuclear factor (HNF)-4alpha-driven epigenetic silencing of the human PED gene. Diabetologia. 2010;53:1482–1492.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Vigliotta G, Trencia A, et al. Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes. 2001;50:1244–1252.
   PubMed Web of Science ®Google Scholar
• Vigliotta G, Miele C, Santopietro S, et al. Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol. 2004;24:5005–5015.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Redina O, Altshuller YM, et al. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem. 2000;275:35224–35232.
   PubMed Web of Science ®Google Scholar
• Miele C, Raciti GA, Cassese A, et al. PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes. 2007;56:622–633.
   PubMed Web of Science ®Google Scholar
• Fiory F, Parrillo L, Raciti GA, et al. PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1. Plos One. 2014;9:e113655.
   PubMed Web of Science ®Google Scholar
• Moon JS, Won KC. Pancreatic α-cell dysfunction in type 2 diabetes: old kids on the block. Diabetes Metab J. 2015;39:1–9.
   PubMed Web of Science ®Google Scholar
• Wolford JK, Bogardus C, Ossowski V, et al. Molecular characterization of the human PEA15 gene on 1q21-q22 and association with type 2 diabetes mellitus in pima Indians. Gene. 2000;241:143–148.
   PubMed Web of Science ®Google Scholar
• Ungaro P, Teperino R, Mirra P, et al. Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. J Biol Chem. 2008;283:30970–30979.
   PubMed Web of Science ®Google Scholar
• Incoronato M, Garofalo M, Urso L, et al. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 2010;70:3638–3646.
   PubMed Web of Science ®Google Scholar
• Perfetti A, Oriente F, Iovino S, et al. Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. J Biol Chem. 2007;282:8648–8657.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674–1685.
   PubMed Web of Science ®Google Scholar
• Heikaus S1, Kempf T, Mahotka C, et al. Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC. Apoptosis. 2008;13:938–949.
   PubMed Web of Science ®Google Scholar
• Sulzmaier F, Opoku-Ansah J, Ramos JW. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small Gtpases. 2012;3:173–177.
   PubMedGoogle Scholar
• Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207–221.
   PubMed Web of Science ®Google Scholar
• Xie X, Bartholomeusz C, Ahmed AA, et al. Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP. Mol Cancer Ther. 2013;12:1099–1111.
   PubMed Web of Science ®Google Scholar
• Funke V, Lehmann-Koch J, Bickeböller M, et al. The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas. Cancer Lett. 2013;335:431–440.
   PubMed Web of Science ®Google Scholar
• Nagarajan A, Dogra SK, Liu AY, et al. PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. Mol Cell Biol. 2014;34:2264–2282.
   PubMed Web of Science ®Google Scholar
• Bartholomeusz C, Itamochi H, Nitta M, et al. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15. Oncogene. 2006;25:79–90.
   PubMed Web of Science ®Google Scholar
• Bartholomeusz C, Rosen D, Wei C, et al. PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res. 2008;68:9302–9310.
   PubMed Web of Science ®Google Scholar
• Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, et al. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin Cancer Res. 2010;16:1802–1811.
   PubMed Web of Science ®Google Scholar
• Shin M, Lee KE, Yang EG, et al. PEA-15 facilitates EGFR dephosphorylation via ERK sequestration at increased ER-PM contacts in TNBC cells. FEBS Lett. 2015;589:1033–1039.
   PubMed Web of Science ®Google Scholar
• Glading A, Koziol JA, Krueger J, et al. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 2007;67:1536–1544.
   PubMed Web of Science ®Google Scholar
• Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, et al. PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence. J Biol Chem. 2004;279:46802–46809.
   PubMed Web of Science ®Google Scholar
• Gawecka JE, Geerts D, Koster J, et al. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer. 2012;131:1556–1568.
   PubMed Web of Science ®Google Scholar
• Formisano P, Perruolo G, Libertini S, et al. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene. 2005;24:7012–7021.
   PubMed Web of Science ®Google Scholar
• Sulzmaier FJ, Valmiki MK, Nelson DA, et al. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene. 2012 Jul 26;31:3547–3560.
   PubMed Web of Science ®Google Scholar
• Bartholomeusz C, Gonzalez-Angulo AM, Liu P, et al. High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients. Oncologist. 2012;17:766–774.
   PubMed Web of Science ®Google Scholar
• Formisano P, Ragno P, Pesapane A, et al. PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. J Cell Mol Med. 2012;16:1435–1446.
   PubMed Web of Science ®Google Scholar
• Zanca C1, Cozzolino F, Quintavalle C, et al. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. J Cell Physiol. 2010;225:63–72.
   PubMed Web of Science ®Google Scholar
• Roos WP, Thomas AD, Kaina B. DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer. 2016;16:20–33.
   PubMed Web of Science ®Google Scholar
• Stassi G, Garofalo M, Zerilli M, et al. PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res. 2005;65:6668–6675.
   PubMed Web of Science ®Google Scholar
• Zanca C, Garofalo M, Quintavalle C, et al. PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J Cell Mol Med. 2008;12:2416–2426.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Romano G, Quintavalle C, et al. Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer. 2007;120:1215–1222.
   PubMed Web of Science ®Google Scholar
• Eckert A, Böck BC, Tagscherer KE, et al. The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene. 2008;27:1155–1166.
   PubMed Web of Science ®Google Scholar
• Siegelin MD, Habel A, Gaiser T. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci Lett. 2008;448:161–165.
   PubMed Web of Science ®Google Scholar
• Obradovic D, Zanca C, Vogl A, et al. Vitamin D3 signalling in the brain enhances the function of phosphoprotein enriched in astrocytes–15 kD (PEA-15). J Cell Mol Med. 2009;13:3315–3328.
   PubMed Web of Science ®Google Scholar
• Fiory F, Formisano P, Perruolo G, et al. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab. 2009;297:E592–601.
   PubMed Web of Science ®Google Scholar
• McDermott M, Wakelam MJ, Morris AJ, et al. Biochem Cell Biol. 2004;82:225–253.
   PubMed Web of Science ®Google Scholar
• Viparelli F, Doti N, Sandomenico A, et al. Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15. Protein Expr Purif. 2008;59:302–308.
   PubMed Web of Science ®Google Scholar
• Viparelli F, Cassese A, Doti N, et al. Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. J Biol Chem. 2008;283:21769–21778.
   PubMed Web of Science ®Google Scholar
• Cassese A, Raciti GA, Fiory F, et al. Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. Plos One. 2013;8:e60555.
   PubMed Web of Science ®Google Scholar
• Doti N, Cassese A, Marasco D, et al. Residues 762-801 of PLD1 mediate the interaction with PED/PEA15. Mol Biosyst. 2010;6:2039–2048.
   PubMed Web of Science ®Google Scholar
• Farina B, Doti N, Pirone L, et al. Molecular basis of the PED/PEA15 interaction with the C-terminal fragment of phospholipase D1 revealed by NMR spectroscopy. Biochim Biophys Acta. 2013;1834:1572–1580.
   PubMed Web of Science ®Google Scholar
• Mercado MM, McLenithan JC, Silver KD, et al. Genetics of insulin resistance. Curr Diab Rep. 2002;2:83–95.
   PubMedGoogle Scholar
• Owen KR, McCarthy MI. Genetics of type 2 diabetes. Curr Opin Genet Dev. 2007;17:239–244.
   PubMed Web of Science ®Google Scholar
• Parker PJ, Coussens L, Totty N, et al. The complete primary structure of protein kinase C the major phorbol ester receptor. Science. 1986;233:853–859.
   PubMed Web of Science ®Google Scholar
• Buteau J, Foisy S, Rhodes CJ, et al. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes. 2001;50:2237–2243.
   PubMed Web of Science ®Google Scholar
• Braz JC, Gregory K, Pathak A, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004;10:248–254.
   PubMed Web of Science ®Google Scholar
• Su W, Chen Q, Frohman MA. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 2009;5:1477–1486.
   PubMed Web of Science ®Google Scholar
• Arkin MR, Randal M, DeLano WL, et al. Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A. 2003;100:1603–1608.
   PubMed Web of Science ®Google Scholar
• Scognamiglio PL, Doti N, Grieco P, et al. Discovery of small peptide antagonists of PED/PEA15-D4α interaction from simplified combinatorial libraries. Chem Biol Drug Des. 2011;77:319–327.
   PubMed Web of Science ®Google Scholar